|
- In the United States, cancer remains the #1 disease killer of children, claiming the lives of more children and young people under the age of 20 than any other disease, and killing more children each year than AIDS, cystic fibrosis, diabetes and asthma combined.
- Childhood cancers are generally more aggressive than cancers that strike adults and, therefore, require extremely aggressive and toxic treatments. For those children who survive the disease and the rigors of treatment, the late effects of the toxic treatments and therapies can be devastating.
- For the past 25 years, the incidence of childhood cancer has steadily grown.
- Curing childhood cancer has become achievable in our lifetime because of progress made through cooperative research of the kind CURE Childhood Cancer funds. Cooperative research has improved the survival rates for childhood cancer from less than 10% to over 77% over the last 40 years.
- At CURE, it is our goal to reach the day when every child with cancer can be guaranteed a cure and when every survivor can live a productive life free from the worries of devastating late effects.
- CURE has raised millions of dollars to fund cutting edge research at the Aflac Cancer Center Blood Disorders Service at Children's Healthcare of Atlanta and Emory University School of Medicine. Through innovative programming focused on meeting the most critical and urgent needs of patients and their families, CURE also provides support for stricken families, providing them comfort and support during their time of devastating need.
- Federal funding for childhood cancer research is tighter now than it has been in over 35 years. CURE is committed to helping the Aflac Cancer Center and Emory University Medical Center bridge the funding gap left by dwindling federal funds. To us, it is imperative that scientific advancements that will help save the lives of children with cancer continue with or without federal funds.
- Because half of the national workforce in pediatric hematology/oncology is more than 15 years from finishing training, thus creating an enormous need for funding fellowships, CURE fully funds two fellows each year as well as the continuing educational expenses of all seven fellows at the Aflac Cancer Center. Over the past five years, CURE has been responsible for the training of nine future pediatric oncologists.
- CURE also funds continuing education of pediatric oncology nurses and staff at the Aflac Cancer Center, thereby helping to ensure the highest level of care to children with cancer in the State of Georgia and beyond.
- In order to advance our mission to secure the brightest future for children with cancer and to provide patients and their families with the support they need, CURE is seeking your generous support to eliminate childhood cancer in our lifetime.
|
|
|
|
